Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $53K 240 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $53K 240 sh |
| Oct 21, 2026 traded Oct 20, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 280 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $148K 640 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 11 | Bitterman KevinDirector |  IRONDisc Medicine, Inc.Open-market sale · 10b5-1 plan | SELL | $475K 5,937 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 11 | Sarowitz Steven IDirector, 10% Owner |  PCTYPaylocity Holding CorpOpen-market sale · 10b5-1 plan | SELL | $759K 4,570 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 11 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $395K 4,942 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 10 | Posey Bruce KCHIEF LEGAL OFFICER |  QLYSQUALYS, INC.Open-market sale · 10b5-1 plan | SELL | $15K 84 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 10 | Posey Bruce KCHIEF LEGAL OFFICER | QLYSQUALYS, INC. Open-market sale · 10b5-1 plan | SELL | $6,554 35 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 10 | Posey Bruce KCHIEF LEGAL OFFICER | QLYSQUALYS, INC. Open-market sale · 10b5-1 plan | SELL | $46K 244 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 10 | Posey Bruce KCHIEF LEGAL OFFICER | QLYSQUALYS, INC. Open-market sale · 10b5-1 plan | SELL | $12K 62 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 10 | Posey Bruce KCHIEF LEGAL OFFICER | QLYSQUALYS, INC. Open-market sale · 10b5-1 plan | SELL | $1,297 7 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 10 | Hohl BenjaminCHIEF FINANCIAL OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $232K 6,018 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 10 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $192K 5,000 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 10 | Rajaram GokulDirector |  PINSPINTEREST, INC.Open-market sale · 10b5-1 plan | SELL | $24K 1,050 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 9 | Rubinstein JuliePresident and COO |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $289K 11.8K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 9 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $286K 11.9K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 8 | Khan Salman HassanChief Financial Officer |  MARAMARA Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $126K 16.0K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 160 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 8 | Baumgartner Jeffrey WEVP, R&D |  CRUSCIRRUS LOGIC, INC.Open-market sale · 10b5-1 plan | SELL | $126K 1,166 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $13K 59 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 8 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Open-market sale · 10b5-1 plan | SELL | $15K 320 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 8 | Piscitelli DominicChief Financial Officer |  ORICOric Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $189K 14.0K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 7 | Sijbrandij SytseDirector |  GTLBGitlab Inc.Open-market sale · 10b5-1 plan | SELL | $2.29M 42.7K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 7 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $1.11M 13.8K sh | Oct 21, 2026 traded Oct 21, 2026 |
| 7 | Sijbrandij SytseDirector | GTLBGitlab Inc. Open-market sale · 10b5-1 plan | SELL | $3.90M 73.5K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 6 | Prahm JeremyChief Investment Officer |  FOAFinance of America Companies Inc.Open-market sale · 10b5-1 plan | SELL | $60K 5,610 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 5 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $9,197 115 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 4 | Patel Rahul G.Director, See remarks below |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $506K 4,302 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 4 | Anderson David HugoDirector |  NWNNorthwest Natural Holding CoOpen-market sale · 10b5-1 plan | SELL | $73K 1,500 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 4 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $191K 2,388 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 4 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $229K 2,869 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 4 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $920K 11.5K sh | Oct 21, 2026 traded Oct 21, 2026 |
| 3 | Garefis AmyEVP, Chief People Officer |  ZIPZIPRECRUITER, INC.Open-market sale · 10b5-1 plan | SELL | $36K 7,879 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $2,485 100 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $151K 5,999 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $150K 5,882 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 1 | Bitterman KevinDirector | IRONDisc Medicine, Inc. Open-market sale · 10b5-1 plan | SELL | $4,397 55 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 1 | Malady KyleEVP and Group CEO-VZ Business |  VZVERIZON COMMUNICATIONS INCOpen-market sale · 10b5-1 plan | SELL | $49K 1,100 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 1 | Ghamsari NimaDirector, HEAD OF BLEND |  BLNDBlend Labs, Inc.Open-market sale · 10b5-1 plan | SELL | $26K 27.8K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner |  STRRStar Equity Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $9,110 1,000 sh | Oct 21, 2026 traded Oct 19, 2026 |